Tumor typea | Tumor name | Histology | Mouse strain | Comments |
---|---|---|---|---|
Breast | MCF7b | Adenocarcinoma | nu/nu NCr | 2 samples P0, 4 samples P1 |
 | MDA-MB-231 T | Adenocarcinoma, from mouse | nu/nu NCr | 2 samples P0 |
Cervical | HeLa-Luc | Adenocarcinoma | nu/nu NCr | 2 samples P0 |
CNS | SF-268c | Anaplastic Astrocytoma | NOD.SCID/NCr | 2 samples P0, P4 and P10 are mouse |
 | SF-539c | Glioblastoma | NOD.SCID/NCr | 2 samples P0, P4 and P10 are mouse |
 | U251 | Glioblastoma | nu/nu NCr | 2 samples P0 |
Colon | COLO 205 | Adenocarcinoma | nu/nu NCr | Â |
 | HCC-2998 | Carcinoma | nu/nu NCr |  |
 | HCT-116 | Carcinoma | nu/nu NCr |  |
 | HCT-15 | Adenocarcinoma | nu/nu NCr |  |
 | HT-29 | Adenocarcinoma, GR III | nu/nu NCr |  |
 | KM12 | Adenocarcinoma | nu/nu NCr |  |
 | SW-620 | Adenocarcinoma | nu/nu NCr |  |
Gastric | GTL 16 | Adenocarcinoma | nu/nu NCr | 2 samples P0 |
Leukemia/ | AS283 | AIDs related Burkitts Lymphoma | SCID/NCr | 2 samples P0 |
Lymphoma | CA46 | B Lymphocyte Burkitts Lymphoma | SCID/NCr | 2 samples P0 |
 | CCRF-CEM | Acute Lymphoblastic Leukemia (T-ALL) | SCID/NCr |  |
 | HL-60(TB) | Promyelocytic Leukemia | SCID/NCr | 3 samples P5 substituted for P4; 4 P0 samples |
 | K-562 | Chronic Myelogenous Leukemia | SCID/NCr | 5 samples P5 substituted for P4, 4 samples P10 |
 | MOLT-4 | Acute Lymphoblastic Leukemia | SCID/NCr |  |
 | SR | Large Cell, Immunoblastic | SCID/NCr |  |
Liver | HuH-7 | Differentiated Hepatocellular Carcinoma | nu/nu NCr | 2 samples P0 |
Lung | A549 | Adenocarcinoma | nu/nu NCr | Â |
 | A549/Asc-1 | Adenocarcinoma | nu/nu NCr | 3 samples P4, 2 samples P0 |
 | EKVX | Adenocarcinoma | SCID/NCr | 2 samples P0 |
 | HOP-62 | Adenocarcinoma | nu/nu NCr | 4 samples P1 |
 | HOP-92 | Large Cell, undifferentiated | nu/nu NCr |  |
 | NCI-H226 | Squamous Carcinoma | nu/nu NCr | 2 samples P1 |
 | NCI-H23 | Adenocarcinoma, NSCLC | nu/nu NCr | 2 samples P0 |
 | NCI-H460 | Large Cell Carcinoma | nu/nu NCr |  |
 | NCI-H522 | Adenocarcinoma | nu/nu NCr | 2 samples P0 |
Melanoma | A375 | Metastatic Malignant Melanoma | nu/nu NCr | 2 samples P0 |
 | COLO 829 | Malignant Melanoma | nu/nu NCr | 2 samples P0 |
 | LOX IMVI | Malignant Amelanocytic Melanoma | nu/nu NCr | 2 samples P0 |
 | M14 | Adenocarcinoma | nu/nu NCr | 2 samples P0 |
 | MALME-3 M | Malignant Melanoma | nu/nu NCr | 2 samples P0, 4 samples P4 |
 | MDA-MB-435 | Adenocarcinoma | nu/nu NCr | 2 samples P0, 3 samples P10 |
 | MDA-Nd | HER2/ERB2 transfectant of MDA-MB-435 | nu/nu NCr | 2 samples P0 |
 | UACC-62 | Malignant Melanoma | nu/nu NCr |  |
Ovarian | CP70 | Carcinoma | nu/nu NCr | 2 samples P0 |
 | OVCAR-3 | Adenocarcinoma | nu/nu NCr | 2 samples P0 |
 | OVCAR-5 | Carcinoma | nu/nu NCr | 2 samples P0 |
Pancreatic | AsPC-1 | Adenocarcinoma | nu/nu NCr | 2 samples P0 |
Prostate | PC-3 | Adenocarcinoma | Male nu/nu NCr | 2 samples P0 |
 | PC-3/Me | Metastatic PC-3 subline | Male nu/nu NCr |  |
Renal | 786-0 | Adenocarcinoma | nu/nu NCr | Â |
 | CAKI-1 | Renal Cell Carcinoma | nu/nu NCr | 2 samples P0 |
 | RXF 393 | Poorly Differentiated Hypernephroma | nu/nu NCr |  |
 | SN12C | Carcinoma | nu/nu NCr | 2 samples P0 |